vs
Amentum Holdings, Inc.（AMTM）与通用电气医疗（GEHC）财务数据对比。点击上方公司名可切换其他公司
通用电气医疗的季度营收约是Amentum Holdings, Inc.的1.6倍（$5.1B vs $3.2B），通用电气医疗净利率更高（8.0% vs 1.4%，领先6.7%），通用电气医疗同比增速更快（7.4% vs -5.2%），通用电气医疗自由现金流更多（$112.0M vs $-142.0M），过去两年Amentum Holdings, Inc.的营收复合增速更高（25.6% vs 3.0%）
本公司是总部位于美国达拉斯的跨国技术专业服务企业，面向全球企业、机构及政府部门客户提供工程、技术、建设服务以及科学与专项咨询服务，连续6年蝉联《工程新闻纪录》（ENR）全球顶尖设计企业500强榜首。
通用电气医疗是总部位于美国伊利诺伊州芝加哥的医疗科技企业，旗下设四大业务板块：医学影像（含分子成像、CT、核磁共振、女性健康筛查、X射线系统）、超声、患者护理解决方案（聚焦远程患者监测、麻醉呼吸护理、心脏病诊断、婴幼儿照护）及制药诊断业务。
AMTM vs GEHC — 直观对比
营收规模更大
GEHC
是对方的1.6倍
$3.2B
营收增速更快
GEHC
高出12.6%
-5.2%
净利率更高
GEHC
高出6.7%
1.4%
自由现金流更多
GEHC
多$254.0M
$-142.0M
两年增速更快
AMTM
近两年复合增速
3.0%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $3.2B | $5.1B |
| 净利润 | $44.0M | $411.0M |
| 毛利率 | 10.1% | 38.5% |
| 营业利润率 | 4.3% | 10.0% |
| 净利率 | 1.4% | 8.0% |
| 营收同比 | -5.2% | 7.4% |
| 净利润同比 | 266.7% | -31.0% |
| 每股收益（稀释后） | $0.18 | $0.85 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AMTMGEHC
| Q1 26 | $3.2B | $5.1B | ||
| Q4 25 | $3.9B | $5.7B | ||
| Q3 25 | — | $5.1B | ||
| Q2 25 | $3.6B | $5.0B | ||
| Q1 25 | $3.5B | $4.8B | ||
| Q4 24 | $3.4B | $5.3B | ||
| Q3 24 | $2.2B | $4.9B | ||
| Q2 24 | $2.1B | $4.8B |
净利润AMTMGEHC
| Q1 26 | $44.0M | $411.0M | ||
| Q4 25 | $40.0M | $588.0M | ||
| Q3 25 | — | $446.0M | ||
| Q2 25 | $10.0M | $486.0M | ||
| Q1 25 | $4.0M | $564.0M | ||
| Q4 24 | $12.0M | $721.0M | ||
| Q3 24 | $26.0M | $470.0M | ||
| Q2 24 | $-26.0M | $428.0M |
毛利率AMTMGEHC
| Q1 26 | 10.1% | 38.5% | ||
| Q4 25 | 10.6% | 39.7% | ||
| Q3 25 | — | 38.7% | ||
| Q2 25 | 10.3% | 39.6% | ||
| Q1 25 | 10.5% | 42.1% | ||
| Q4 24 | 10.6% | 42.8% | ||
| Q3 24 | 9.0% | 41.7% | ||
| Q2 24 | 9.6% | 41.4% |
营业利润率AMTMGEHC
| Q1 26 | 4.3% | 10.0% | ||
| Q4 25 | 3.4% | 14.5% | ||
| Q3 25 | — | 12.7% | ||
| Q2 25 | 2.9% | 13.1% | ||
| Q1 25 | 3.2% | 13.2% | ||
| Q4 24 | 3.9% | 15.1% | ||
| Q3 24 | 1.2% | 13.9% | ||
| Q2 24 | 4.2% | 12.6% |
净利率AMTMGEHC
| Q1 26 | 1.4% | 8.0% | ||
| Q4 25 | 1.0% | 10.3% | ||
| Q3 25 | — | 8.7% | ||
| Q2 25 | 0.3% | 9.7% | ||
| Q1 25 | 0.1% | 11.8% | ||
| Q4 24 | 0.4% | 13.6% | ||
| Q3 24 | 1.2% | 9.7% | ||
| Q2 24 | -1.2% | 8.8% |
每股收益（稀释后）AMTMGEHC
| Q1 26 | $0.18 | $0.85 | ||
| Q4 25 | $0.16 | $1.28 | ||
| Q3 25 | — | $0.98 | ||
| Q2 25 | $0.04 | $1.06 | ||
| Q1 25 | $0.02 | $1.23 | ||
| Q4 24 | $0.05 | $1.58 | ||
| Q3 24 | $0.31 | $1.02 | ||
| Q2 24 | $-0.29 | $0.93 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $247.0M | — |
| 总债务越低越好 | $3.9B | $10.1B |
| 股东权益账面价值 | $4.6B | $10.7B |
| 总资产 | $11.2B | $37.1B |
| 负债/权益比越低杠杆越低 | 0.86× | 0.95× |
8季度趋势，按日历期对齐
现金及短期投资AMTMGEHC
| Q1 26 | $247.0M | — | ||
| Q4 25 | $437.0M | $4.5B | ||
| Q3 25 | — | $4.0B | ||
| Q2 25 | $738.0M | $3.7B | ||
| Q1 25 | $546.0M | $2.5B | ||
| Q4 24 | $522.0M | $2.9B | ||
| Q3 24 | $452.0M | $3.5B | ||
| Q2 24 | — | $2.0B |
总债务AMTMGEHC
| Q1 26 | $3.9B | $10.1B | ||
| Q4 25 | $3.9B | $10.0B | ||
| Q3 25 | — | $10.3B | ||
| Q2 25 | $4.5B | $10.3B | ||
| Q1 25 | $4.7B | $8.8B | ||
| Q4 24 | $4.7B | $9.0B | ||
| Q3 24 | $4.7B | $10.3B | ||
| Q2 24 | — | $9.2B |
股东权益AMTMGEHC
| Q1 26 | $4.6B | $10.7B | ||
| Q4 25 | $4.5B | $10.4B | ||
| Q3 25 | — | $10.0B | ||
| Q2 25 | $4.5B | $9.7B | ||
| Q1 25 | $4.4B | $9.2B | ||
| Q4 24 | $4.5B | $8.4B | ||
| Q3 24 | $4.5B | $8.3B | ||
| Q2 24 | $303.0M | $7.8B |
总资产AMTMGEHC
| Q1 26 | $11.2B | $37.1B | ||
| Q4 25 | $11.5B | $36.9B | ||
| Q3 25 | — | $36.1B | ||
| Q2 25 | $11.8B | $35.5B | ||
| Q1 25 | $12.0B | $33.6B | ||
| Q4 24 | $11.9B | $33.1B | ||
| Q3 24 | $12.0B | $33.9B | ||
| Q2 24 | — | $31.9B |
负债/权益比AMTMGEHC
| Q1 26 | 0.86× | 0.95× | ||
| Q4 25 | 0.88× | 0.96× | ||
| Q3 25 | — | 1.03× | ||
| Q2 25 | 1.01× | 1.06× | ||
| Q1 25 | 1.06× | 0.95× | ||
| Q4 24 | 1.05× | 1.06× | ||
| Q3 24 | 1.05× | 1.24× | ||
| Q2 24 | — | 1.18× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-136.0M | — |
| 自由现金流经营现金流 - 资本支出 | $-142.0M | $112.0M |
| 自由现金流率自由现金流/营收 | -4.4% | 2.2% |
| 资本支出强度资本支出/营收 | 0.2% | — |
| 现金转化率经营现金流/净利润 | -3.09× | — |
| 过去12个月自由现金流最近4个季度 | $272.0M | — |
8季度趋势，按日历期对齐
经营现金流AMTMGEHC
| Q1 26 | $-136.0M | — | ||
| Q4 25 | $270.0M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $106.0M | $94.0M | ||
| Q1 25 | $57.0M | $250.0M | ||
| Q4 24 | $110.0M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $-119.0M |
自由现金流AMTMGEHC
| Q1 26 | $-142.0M | $112.0M | ||
| Q4 25 | $261.0M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $100.0M | $8.0M | ||
| Q1 25 | $53.0M | $98.0M | ||
| Q4 24 | $102.0M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $-183.0M |
自由现金流率AMTMGEHC
| Q1 26 | -4.4% | 2.2% | ||
| Q4 25 | 6.6% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 2.8% | 0.2% | ||
| Q1 25 | 1.5% | 2.1% | ||
| Q4 24 | 3.0% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -3.8% |
资本支出强度AMTMGEHC
| Q1 26 | 0.2% | — | ||
| Q4 25 | 0.2% | 2.4% | ||
| Q3 25 | — | 2.1% | ||
| Q2 25 | 0.2% | 1.7% | ||
| Q1 25 | 0.1% | 3.2% | ||
| Q4 24 | 0.2% | 1.9% | ||
| Q3 24 | — | 1.9% | ||
| Q2 24 | — | 1.3% |
现金转化率AMTMGEHC
| Q1 26 | -3.09× | — | ||
| Q4 25 | 6.75× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 10.60× | 0.19× | ||
| Q1 25 | 14.25× | 0.44× | ||
| Q4 24 | 9.17× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -0.28× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AMTM
| Global Engineering Solutions Segment | $1.9B | 59% |
| Other U.S.Government Agencies | $400.0M | 12% |
| Fixed Price Contract | $380.0M | 12% |
| Commercial And International | $226.0M | 7% |
| Time And Materials Contract | $171.0M | 5% |
| Sales Channel Through Intermediary | $78.0M | 2% |
| Equity Method Investee | $50.0M | 2% |
GEHC
| Imaging revenues | $2.3B | 45% |
| AVS revenues | $1.3B | 26% |
| PDx revenues | $770.0M | 15% |
| PCS revenues | $704.0M | 14% |
| Other revenues | $18.0M | 0% |
